SAB Biotherapeutics, Inc. (SABS)

NASDAQ: SABS · IEX Real-Time Price · USD

2.840

-0.010 (-0.35%)

At close: Jul 19, 2024, 12:00 AM

2.880

+0.040 (1.41%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

SAB Biotherapeutics Employees

SAB Biotherapeutics had 57 employees as of December 31, 2023. The number of employees increased by 1 or 1.79% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

1.79%

Revenue / Employee

$45,657

Profits / Employee

-$699,398

Market Cap

26.21M

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2023	57	1	1.79%
Dec 31, 2022	56	-83	-59.71%
Dec 31, 2021	139	53	61.63%
Dec 31, 2020	86	-	-

Company Name	Employees
ATI Physical Therapy	6,000
Beyond Air	107
Renalytix	102
Acasti Pharma	32
Brainstorm Cell Therapeutics	29
RenovoRx	8
Autonomix Medical	8
NeuroBo Pharmaceuticals	8